BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22221577)

  • 1. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical therapy of hilar cholangiocarcinoma].
    Lang H; Kaiser GM; Zöpf T; Sotiropoulos GC; Frilling A; Malagó M; Broelsch CE
    Chirurg; 2006 Apr; 77(4):325-34. PubMed ID: 16568258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hilar resection in the treatment of hilar cholangiocarcinoma.
    Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K
    Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hilar cholangiocarcinoma.
    Robles R; Sánchez-Bueno F; Ramírez P; Brusadin R; Parrilla P
    World J Gastroenterol; 2013 Dec; 19(48):9209-15. PubMed ID: 24409049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
    Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
    HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical technique and results of intrapancreatic bile duct resection for hilar malignancy (with video).
    Noji T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Tsuchikawa T; Hirano S
    HPB (Oxford); 2018 Dec; 20(12):1145-1149. PubMed ID: 29941288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).
    Dinant S; Gerhards MF; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
    Ann Surg Oncol; 2006 Jun; 13(6):872-80. PubMed ID: 16614876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
    Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group.
    Regimbeau JM; Fuks D; Pessaux P; Bachellier P; Chatelain D; Diouf M; Raventos A; Mantion G; Gigot JF; Chiche L; Pascal G; Azoulay D; Laurent A; Letoublon C; Boleslawski E; Rivoire M; Mabrut JY; Adham M; Le Treut YP; Delpero JR; Navarro F; Ayav A; Boudjema K; Nuzzo G; Scotte M; Farges O;
    HPB (Oxford); 2015 Jan; 17(1):79-86. PubMed ID: 24992279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.